PPARD Antibody (LS-B1605)

貨號 Cat. No.
LS-B1605
規格 Size
50 µg
品牌 Brand
LSBio

Description





























































































Antibody Catalog ID: LS-B1605
Antibody Validation: This antibody replaces catalog number LS-C11183. It has been validated for use in the following assays: IHC.
Antibody Target: Peroxisome Proliferator-Activated Receptor Beta/Delta (PPARD)
Synonyms: PPARD, Nr1c2, nuci, peroxisome proliferator activated receptor beta, Peroxisome proliferator activated receptor delta, ppar beta, Ppar-delta, pparb/d, pparbeta, PPARbeta/delta, ppard, ppardelta
Family: NHR
Subfamily: NR1 Thyroid hormone-like
Host: PPARD antibody was produced in Rabbit
Antigen Species: PPARD antibody was raised against Human
Clonality: Polyclonal
Isotype: IgG
Antigen Type: Synthetic peptide - KLH conjugated
Immunogen: PPARD antibody was raised against synthetic peptide
Antibody Specificity: Human PPAR delta amino acids 39-54 (SSSYTDLSRSSSPPSL)
Antigen Modification: aa39-54
Predicted Species Reactivity: Mouse, Porcine, Rat, Sheep
Purification: Immunoaffinity Chromatography
Presentation: TBS, 50% glycerol, 0.1% BSA, 0.02% sodium azide.
Recommended Storage: Long term: -20°C; Short term: +4°C
Antibody Usage Summary: Immunohistochemistry: LS-B1605 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody LS-D1, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B1605 was determined to be 5 ug/ml.
Antibody Uses: Immunohistochemistry - Paraffin (IHC-P) (5 µg/ml), Immunocytochemistry (ICC), Western blot (WB) (Optimal dilution to be determined by the researcher)
Size: 50 µg
Concentration: 0.6 mg/ml

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢